CytoDyn (CYDY) Net Equity Issued and Repurchased (2010 - 2021)
CytoDyn's (CYDY) quarterly Net Equity Issued and Repurchased came in at $10.7 million in Q4 2021, up 970.0% YoY from $1.0 million in Q4 2020, and up 268.97% on a QoQ basis from $2.9 million in Q3 2021.
CytoDyn (CYDY) Net Equity Issued and Repurchased (2010 - 2021) Analysis & Trends
CytoDyn (CYDY) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $10.7 million in Q4 2021.
- Quarterly Net Equity Issued and Repurchased rose 970.0% year-over-year to $10.7 million in Q4 2021, while the trailing twelve-month figure through May 2022 was $11.7 million (changed N/A YoY) and the FY2022 annual result came in at $11.4 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased improved to $10.7 million in Q4 2021, from $2.9 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $12.3 million in Q2 2020 to a low of $1.0 million in Q4 2020.
- A 3-year average of $7.2 million and a median of $7.5 million in 2019 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2020 — Net Equity Issued and Repurchased plunged 76.74% — and 2021, when it jumped 970.0%.
- Tracing CYDY's Net Equity Issued and Repurchased over 3 years: stood at $4.3 million in 2019, then sank by 76.74% to $1.0 million in 2020, then jumped by 970.0% to $10.7 million in 2021.
- The last three Net Equity Issued and Repurchased figures came in at $10.7 million (Q4 2021), $2.9 million (Q3 2021), and $1.0 million (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2021 | 10.70 Mn |
| Nov 30, 2021 | 10.70 Mn |
| Aug 31, 2021 | 2.90 Mn |
| Aug 31, 2021 | 2.90 Mn |
| Nov 30, 2020 | 1.00 Mn |
| Nov 30, 2020 | 1.00 Mn |
| May 31, 2020 | 12.30 Mn |
| May 31, 2020 | 12.30 Mn |
| Nov 30, 2019 | 4.30 Mn |
| Nov 30, 2019 | 4.30 Mn |
| Aug 31, 2019 | 11.90 Mn |
| Aug 31, 2019 | 11.90 Mn |
| Feb 29, 2012 | 3.00 Mn |
| Feb 29, 2012 | 3.00 Mn |
| May 31, 2011 | 1.03 Mn |
| May 31, 2011 | 1.03 Mn |
| Feb 28, 2011 | 1.05 Mn |
| Feb 28, 2011 | 1.05 Mn |
| Nov 30, 2010 | 250,000.00 |
| Nov 30, 2010 | 250,000.00 |